Clinical Trials Browser

Recruiting × Neoplasms × Olanzapine × Clear all

NCT05705492 2026-01-21

Olanzapine for the Management of Cancer Associated Appetite Loss in Patients With Advanced Esophagogastric, Hepatopancreaticobiliary, Colorectal or Lung Cancer

Phase 2 Recruiting

Gastrointestinal

Anorexia, Cachexia, Esophageal Neoplasms, Neoplasms, Colorectal Neoplasms, Weight Loss

NCT03118986 2025-10-08

RCT of Olanzapine for Control of CIV in Children Receiving Highly Emetogenic Chemotherapy

Phase 2 Recruiting

Nausea, Neoplasms, Vomiting

NCT06500234 2024-07-15

Nutrition Impact on Immunotherapy of Cancer

Phase 3 Recruiting

Neoplasms, Nutrition Disorders, Prosthesis Failure